Medical Devices

SHL buyout looks to advance self-injection drug delivery offering

31-Mar-2020 By Vassia Barba

With the acquisition of Weibel, SHL Medical looks to the development of novel drug delivery systems for self-administration, answering a need for improved patient-centricity in the sector.

Signant and Propeller partner to improve inhaler adherence with sensor

09-Jan-2020 By Ben Hargreaves

The two companies will combine their digital health services to offer clinical trial participants an inhaler equipped with a sensor to analyze patient adherence.

Pharma companies slow to adopt AI will be ‘left behind’

11-Dec-2019 By Ben Hargreaves

Though pharma companies now accept the value of AI and machine learning, extra effort is required by the industry to realize the potential business and patient benefits, says Iqvia exec.

Recipharm strikes £505M takeover of Consort

25-Nov-2019 By Nick Taylor

Recipharm strikes £505m takeover of Consort Medical to leapfrog into top tier of CDMOs.

AI in drug development: ACRO, DIA, and Owkin to talk use cases and what comes next

18-Sep-2019 By Melissa Fassbender

There has been a lot of discussion surrounding the use of artificial intelligence in drug development – with several deals, alliances, and partnerships made so far this year. Here, Outsourcing-Pharma takes a look back at some of these announcements, as...

Standardized eCOA questionnaire library will speed study start up: Medidata

16-Sep-2019 By Melissa Fassbender

Medidata is building a global library of pre-configured, pre-approved eCOA questionnaires to accelerate study start-up in collaboration with Icon's Mapi Research Trust – “a win-win-win” for all involved.

Using voice-enabled technology to ‘better understand the patient’

11-Sep-2019 By Vassia Barba

Patients often feel more comfortable sharing their feelings with a device than with a health care provider, found researchers at Janssen, who have developed a new voice technology application for clinical trials.

‘Everything to do with patient centricity’: Wearables to redefine research approaches

11-Sep-2019 By Melissa Fassbender

After ‘holding its breath’ for nearly half a decade, pharma and health care companies are ready to implement new technology in clinical trials – though data standardization will be key to fully realizing the benefits.

Veeva adds to Vault regulatory capabilities for medical devices, diagnostics

29-Aug-2019 By Melissa Fassbender

Veeva Systems has boosted its capabilities in its Veeva Vault RIM to manage regulatory documents and processes for medical devices and diagnostics manufacturers.

Innovation at scale: Oracle, HCL look to clear an ‘easy adoption path’ for mHealth in clinical trials

08-Aug-2019 By Melissa Fassbender

HCL Technologies and Oracle Health Sciences announce a collaboration to “bridge the gap” between the potential of mobile health and the realities of adoption, says EVP.

4 lessons learned from conducting virtual trials: A sit-down with Iqvia

06-Aug-2019 By Melissa Fassbender

It’s a lot more complicated than a simple technology – says Iqvia global head of virtual trials, who shares four lessons learned during a discussion at the company’s headquarters in Research Triangle Park.

Immodulon adopts AI tool to accelerate pancreatic cancer clinical trial

30-Jul-2019 By Vassia Barba

Immodulon to utilize biomarkers identified by Biodesix’ machine learning platform, aiming to accelerate the clinical development of its pancreatic treatment.

Litmus Health releases next-gen clinical research platform

30-Jul-2019 By Melissa Fassbender

Litmus Health today released a new version of its end-to-end real-world data platform for clinical research – as the industry increasingly adopts wearable technology to monitor patients in their homes, says CMO.

Biofourmis study uses wearables to improve patient centricity in heart failure trials

25-Jul-2019 By Vassia Barba

A study by Biofourmis aims to improve patient centricity in the drug approval processes by using wearable technology and mobile software to monitor the quality of life for patients with heart failure.

The Living Heart: FDA renews contract with Dassault to evaluate 3D simulation, virtual patients

24-Jul-2019 By Melissa Fassbender

Dassault Systèmes’ Living Heart Project is moving forward with an in silico clinical trial underway and plans to evaluate the use of virtual patients – as the French software company hopes to reduce costs, timelines, and improve quality across the industry,...